This panel will provide real life practical solutions to the question the cannabis industry faces: how do we level the playing field in a highly regulated, highly competitive industry? We will discuss how to practically implement social equity efforts beyond what states and municipalities have been offering and discuss recommendations for federal legalization.
Panelists will explore the current state of cannabis legalization in various regions throughout the Americas and highlight emerging markets with high growth potential. Attendees will leave this panel with a deeper understanding of the current state and future potential of emerging cannabis markets in the Americas, as well as insights and strategies for success in these exciting and rapidly evolving markets.
This panel will discuss, among other things: (i) the goals of implementing solid corporate governance infrastructure including transparency, equity among shareholders, and maintaining the integrity and legitimacy of a cannabis company in particular; (ii) the importance of advising clients about best practices for effectively maintaining and enforcing corporate governance systems by, including, but not limited to, adhering to the often-overlooked federal guidelines from the United States Sentencing Commission; and (iii) the importance of implementing corporate governance controls and policies during a company’s infancy; and (iv) lessons learned from high-profile cannabis companies whose poor corporate governance practices had a damaging impact, including companies like Namaste Technologies.
Attendees will gain an overview of the UK Cannabis markets, including an overview of the small but growing medical segment, as well as the booming CBD and wellness industries.
Take a look at how to shore up those international supply chain needs, the potential of interstate commerce under state-implemented Memoranda of Understanding, and the future of supply chain consistency in a post-legalized world.
This panel seeks to address the pathways for federal cannabis reform in the 117th
Congress, considering legislative vehicles, political pragmatism, and actions of the
Administration.
This panel of experienced practitioners will provide insight and guidance in spotting and trouble shooting the issues at the early stages of the evaluation and negotiation of cannabis business transactions.
Global Cannabis Intellectual Property Symposium 2023 session: Ethics: Balancing Activism and Zealous Advocacy with the Boundaries of the Profession and Evolving Law